The biotechnology company explained that Pombiliti is a recombinant human GAA enzyme naturally expressed with high levels of bis-M6P, designed for increased uptake into muscle cells, whereas ...

Pombiliti + Opfolda is a two-component therapy. Pombiliti is a recombinant human GAA enzyme (rhGAA) naturally expressed with high levels of bis-M6P (Mannose 6-Phosphate), designed for increased uptake ...

Ulster GAA’s CEO has said he is “hopeful” of receiving funding for Casement Park after meeting with UK MPs in Westminster for the first time.

Mayo GAA confirms €7.8m debt to Croke Park, gardaí contacted over abuse campaign, and Kevin McStay steps back due to health reasons ...

Mayo GAA has denied claims of financial mismanagement while revealing An Garda Síochána have been informed of “threatening and abusive” emails sent to county board officers.

GAA club lead tributes following death of 'true Gael' as family make heartbreaking funeral request The talented footballer has been remembered for the "huge impact he had on his community, both on ...

A Democratic Unionist Party minister has attended his first GAA match. Communities Minister Gordon Lyons was at Armagh's Athletic Grounds to watch the home side, the current All-Ireland champions ...

GAA President Jarlath Burns has called on the GAA community to “stand together to honour those we have lost and to demand action before more lives are needlessly taken” on the A5 road.

With rural depopulation and more and more people living in Dublin, there’s a crisis in the GAA that you should care about ...

Pombiliti + Opfolda, is a two-component therapy that consists of cipaglucosidase alfa-atga, a bis-M6P-enriched rhGAA that facilitates high-affinity uptake through the M6P receptor while retaining its ...

One of the GAA’s top nutritionists has revealed the biggest no-no when it comes to preparation and recovery in sport. Niamh Mallon is a nutritionist for the Galway senior footballers, while she ...

>3,000 People Treated with an Amicus Therapy Today2 PRINCETON, N.J., Jan. 12, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on ...